NCT02592798 · Interventional trial
Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
Overall registry status Completed
Phase 2
Conditions Focal Segmental Glomerulosclerosis, Minimal Change Disease, Nephrotic Syndrome
Delaware Valley sites
- University Of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory